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Introduction {#sec1}
============

Proper cognitive development and brain function rely on synaptic plasticity, the ability of synapses to strengthen or weaken in response to sensory or neuromodulatory inputs. Synaptic scaling is one mechanism of plasticity, which buffers potentially destabilizing patterns of network activity ([@bib1]; [@bib44]; [@bib58]). In response to a sustained increase in neuronal firing rate, neurons decrease, or "scale down," the receptivity of the neuron to excitatory neurotransmitters. Conversely, global decreases in firing rate cause neurons to "scale up" and increase synaptic efficacy. Synaptic scaling can accommodate other forms of plasticity, such as long-term potentiation (LTP), that impose long-lasting increase of individual synaptic efficacy, which left uncompensated would result in circuits that are overly active ([@bib59]). Synaptic scaling plays important roles in neurodevelopment, learning, and memory ([@bib21]; [@bib64]). Dysregulated homeostatic plasticity is a common pathological hallmark in several neurodevelopmental disorders, including fragile X syndrome ([@bib55]), Rett syndrome ([@bib70]), tuberous sclerosis ([@bib3]), Kleefstra syndrome ([@bib4]), and some autism spectrum conditions ([@bib9]).

Synaptic scaling requires *de novo* synthesis of RNAs and proteins that directly modulate synaptic efficacy ([@bib5]; [@bib31]; [@bib32]). DNA-binding transcription factors (TFs), such as cyclic AMP-response binding protein (CREB), drive transcriptional responses to neuronal activation ([@bib62]). The initial response is a rapid induction of immediate-early genes, such as *Arc* and *Homer1* ([@bib11]; [@bib12]). The gene expression programs triggered by reductions in network activity involves distinct TFs, such as SRF and ELK1 ([@bib53]).

In eukaryotic cells, transcriptional responses must occur in a refractory environment in which DNA is packaged into chromatin. The strong linkage between cognitive disorders and chromatin-regulatory genes suggests that activity-dependent chromatin reorganization is essential for proper brain development and mental health ([@bib17]; [@bib25]; [@bib45]). Indeed, activity-dependent gene expression underlying LTP and memory requires chromatin regulators, such as histone acetyltransferases and deacetylases ([@bib13]). A handful of chromatin regulators, TET3 DNA demethylase ([@bib66]), EHMT1/2 histone H3K9 methyltransferases ([@bib4]), and L3MBTL1 methyl-histone binding factor ([@bib43]) affect synaptic scaling. Yet these molecules constitute an infinitesimal fraction of the many chromatin regulators that have genetic links to neurodevelopmental disorders. We do not know the extent to which disease-associated chromatin regulators play roles in transcription-dependent synaptic plasticity.

Another unresolved issue is the precise mechanisms by which these chromatin regulators contribute to transcription. To dissect the mechanism, accurate monitoring of transcriptional responses is critical. Most prior studies have monitored steady-state mRNA levels, using qRT-PCR, cDNA microarray, and mRNA sequencing (mRNA-seq). The brain exhibits notorious complexity of post-transcriptional regulation, including activity-dependent mRNA splicing ([@bib27]), mRNA decay ([@bib63]), mRNA transport, and local translation ([@bib24]). Therefore, reliance on steady-state mRNA measurements may obscure the roles of chromatin regulators in transcription.

In the present work, we developed genome-wide measurement of bona fide transcriptional dynamics in response to bidirectional network activity alterations. We then used this approach to uncover a role for the chromatin regulator retinoic acid-induced 1 (RAI1) in the transcriptional program. RAI1 is a nucleosome-binding protein ([@bib15], [@bib16]) and is expressed throughout the embryonic and adult brain ([@bib29]). *RAI1* is associated with two human intellectual disability syndromes. *RAI1* haploinsufficiency leads to Smith-Magenis syndrome (SMS; MIM: [182290](182290){#intref0010}), while *RAI1* duplication results in Potocki-Lupski syndrome (PTLS; MIM: [610883](610883){#intref0015}) ([@bib6]; [@bib23]; [@bib50]; [@bib54]). Studies in mouse models and human patient cells have uncovered roles of RAI1 in gene expression, neuronal structure, and behavior ([@bib7], [@bib8]; [@bib29], [@bib30]; [@bib37]). However, no study has described RAI1 in activity-dependent transcription and synaptic plasticity to date. We therefore explored the roles of RAI1 in activity-dependent transcription and synaptic scaling.

Results {#sec2}
=======

Altered Neuronal Network Activity Triggers Genome-wide Transcriptional Changes {#sec2.1}
------------------------------------------------------------------------------

To overcome the major limitation of steady-state RNA sequencing (RNA-seq), we adopted bromouridine sequencing (BrU-seq), a genome-wide profiling technique of nascent transcripts ([@bib48], [@bib49]). We prepared primary forebrain neuron cultures from embryonic day 18 (E18) mouse embryos and allowed them to mature for 17 days *in vitro* (DIV). To monitor bidirectional transcriptional responses to activity shifts, network activity was elevated by 20 μM bicuculline (BIC; a GABA~A~ receptor antagonist) or suppressed by 1 μM tetrodotoxin (TTX; a sodium channel blocker) for 4 h. During the last 20 min of BIC or TTX treatment, we added BrU to the culture medium to label newly synthesized transcripts. We isolated the labeled RNAs using an anti-BrU antibody and subjected them to next-generation sequencing ([Figure 1](#fig1){ref-type="fig"} A).Figure 1Genome-wide Transcriptional Response to Bidirectional Activity Alterations(A) Experimental procedure.(B) UCSC Browser views of BrU-seq signals at *Arc* and *Fos*. Intronic reads are characteristic of nascent RNA.(C) Differential gene expression analysis (DESeq2) reveals widespread transcriptional changes in response to TTX and BIC (p~adj~ \< 0.05).(D) BIC-response genes show a greater median fold change (Wilcoxon rank-sum test). Whiskers represent 1.5 times the inter-quartile range (IQR), and the notch represents the 95% confidence interval of the median.(E) Downregulation of immediate-early gene in the TTX condition is captured more sensitively in BrU-seq data compared with mRNA-seq data ([@bib66]).(F) The majority of TTX and BIC response genes are uniquely regulated (70%). 24% of genes are reciprocally regulated, and 6% are commonly regulated.See also [Figure S1](#mmc1){ref-type="supplementary-material"} and [Tables S1](#mmc2){ref-type="supplementary-material"} and [S2](#mmc3){ref-type="supplementary-material"}.

Our BrU-seq dataset demonstrated the expected induction of *Arc* and *Fos* by BIC ([Figure 1](#fig1){ref-type="fig"}B). Abundant intronic reads indicate that detected transcripts were recently generated and yet to be spliced. Other well-characterized activity-dependent genes, such as *Npas4*, *Egr1*, *Homer1*, *Tet3*, and *Txnip*, also showed expected transcriptional induction ([Table S1](#mmc2){ref-type="supplementary-material"}). Differential gene expression analysis of the BrU-seq data using DESeq2 ([@bib42]) revealed widespread transcriptional changes, in which 45% of expressed genes (7,592 of 16,682) were up- or downregulated by network activity shifts (p~adj~ \< 0.05; [Figure 1](#fig1){ref-type="fig"}C). BIC increased transcription of 2,908 genes, while TTX did so for 1,820 genes. The magnitude of transcriptional induction is higher with BIC treatment compared with TTX treatment ([Figure 1](#fig1){ref-type="fig"}D). To examine the relationship between nascent and steady-state transcriptomes, we compared our BrU-seq data with published mRNA-seq datasets of mouse cortical neurons treated with TTX or BIC for 4 or 6 h ([@bib53]; [@bib66]) with identical data processing. Our 4 h BrU-seq results showed a much stronger similarity with 4 h mRNA-seq than 6 h mRNA-seq data ([Figure S1](#mmc1){ref-type="supplementary-material"}B). Thus, BrU-seq reliably captures known transcriptional responses to bidirectional shifts in network activity.

BrU-seq might be a better approach than mRNA-seq to detect downregulation of transcription, because the persistence of RNAs after transcription does not contribute to BrU-seq signals. Indeed, we found significantly larger suppression of *Fos*, *Arc*, *Bdnf*, and *Npas4* (4- to 16-fold) by TTX treatment in BrU-seq compared with mRNA-seq performed with 4 h BIC and TTX treatments, in which downregulation was less than 2-fold ([Figure 1](#fig1){ref-type="fig"}E) ([@bib53]; [@bib66]). The magnitude of upregulation in response to BIC was smaller in BrU-seq, likely because the early transcriptional induction is largely complete 4 h after BIC treatment. At a genome-wide scale, BrU-seq allowed us to detect transcriptional suppression of numerous genes (BIC, n = 2,842; TTX, n = 2,307). These data highlight an advantage of the BrU-seq approach to probe mechanisms underlying highly dynamic activity-dependent transcription.

On the basis of the behavior of well-defined activity-response genes ([Figure 1](#fig1){ref-type="fig"}E), one could assume that BIC and TTX trigger reciprocal transcriptional responses. Unexpectedly, only a small fraction of activity-response genes (24% \[1,798 of 7,592\]) displayed such mirrored responses between BIC and TTX treatments ([Figure 1](#fig1){ref-type="fig"}F). Six percent of activity-response genes (487 of 7,592) altered their transcription levels in the same direction after BIC and TTX treatments. The remaining majority of genes (70% \[5,307 of 7,592\]) responded to BIC or TTX uniquely. These data suggest that synaptic up- and downscaling involves distinct transcriptional programs. [Table S1](#mmc2){ref-type="supplementary-material"} lists genes that displayed greater than 2-fold changes in transcription upon network activity shifts.

Recent studies have reported that different cell types, such as astrocytes and neuronal subtypes, induce distinct sets of genes in an activity-dependent manner ([@bib26]; [@bib28]). We sought to assess the contribution of various cell types in our datasets. Using immunocytochemistry of a set of cell type markers, NeuN, GAD67, GFAP, CD11b, and Olig2, we estimated that our cultures comprise 41% excitatory neurons, 11% inhibitory neurons, 33% astrocytes, 15% of cells within the oligodendrocyte lineage, and no microglia ([Figures S1](#mmc1){ref-type="supplementary-material"}D and S1E). We found several non-neuronal genes in our dataset, including *Thbs1*, a synaptic regulator expressed specifically in astrocytes ([@bib51]). We detected enrichment of biological processes specific for both neurons and non-neuronal cell types ([Table S2](#mmc3){ref-type="supplementary-material"}). Intersection of the BrU-seq data with published cell-type-enriched genes ([@bib69]) revealed that the majority (\>80%) of the activity-response genes do not exhibit cell type-specific expression ([Figure S1](#mmc1){ref-type="supplementary-material"}F). Thus, the present dataset represents an aggregate view of transcriptional response occurring in multiple cell types.

RAI1 Suppresses the TTX-Induced Transcriptional Program in Resting Networks {#sec2.2}
---------------------------------------------------------------------------

RAI1 is one of many chromatin regulators that are mutated in neurodevelopmental disorders. Little is known about RAI1's roles in activity-dependent transcription and synaptic plasticity. We developed an anti-RAI1 antibody and confirmed that RAI1 protein was present in virtually all MAP2-positive neurons and primarily localized to the nucleus, with subtle signals in the soma ([Figure S2](#mmc1){ref-type="supplementary-material"}A). We found lower RAI1 levels in non-neuronal (MAP2-negative) cell nuclei ([Figure S2](#mmc1){ref-type="supplementary-material"}A), highlighting its important role in neurons. Widespread presence of RAI1 in neurons is consistent with previous studies ([@bib22]; [@bib29]) ([Figures S2](#mmc1){ref-type="supplementary-material"}B and S2C).

Having established nascent transcriptional profiling in neural ensembles and the presence of RAI1 in our cultures, we sought to test if RAI1 has any roles in synaptic scaling and transcriptional responses to altered neuronal activity. We knocked down *Rai1* in primary cortical cultures using lentiviral vectors (LVs) carrying *Rai1* or scrambled short hairpin RNAs (shRNAs) (sh-Ctrl). To minimize the impact of RAI1 loss on network connectivity, we delivered LV shRNA at DIV 14, a time by which functional synapses have formed. The knockdown (KD) achieved near complete loss of RAI1 protein by 3 days post-LV infection ([Figure 2](#fig2){ref-type="fig"} A). We then modulated network activity of LV-treated cultures by applying TTX or BIC for 4 h and carried out BrU-seq as described above.Figure 2*Rai1* KD Alters Transcription of TTX-Response Genes at Baseline(A) Validation of *Rai1* KD with western blot. Mouse forebrain neuron cultures were transduced with lentivirus expressing sh-*Rai1* or sh-Ctrl for 3 days.(B) Number of DESeq2-called differentially expressed genes (sh-Ctrl versus sh-*Rai1*, p~adj~ \< 0.05) after vehicle treatment.(C) Many *Rai1*-KD DE genes are TTX- and BIC-response genes.(D) The fold changes of TTX- and BIC-response genes by *Rai1* KD at baseline. Note that *Rai1*-KD cultures display a transcriptional profile similar to TTX-treated control cultures. r, Spearman's rank correlation coefficient.See also [Figure S2](#mmc1){ref-type="supplementary-material"} and [Tables S3](#mmc4){ref-type="supplementary-material"} and [S4](#mmc5){ref-type="supplementary-material"}.

We initially tested if *Rai1* KD alters nascent transcription in control "resting" neuronal cultures with stable basal levels of activity. DESeq2 analysis revealed 122 differentially expressed (DE) genes: 104 downregulated and 18 upregulated following *Rai1* KD (p~adj~ \< 0.05; [Figure 2](#fig2){ref-type="fig"}B; [Table S3](#mmc4){ref-type="supplementary-material"}). The finding that *Rai1* KD downregulates more genes than it upregulates is consistent with the previous studies on RAI1 ([@bib19]; [@bib29]). A majority of genes altered by *Rai1* KD at baseline were BIC- or TTX-response genes ([Figure 2](#fig2){ref-type="fig"}C). To further characterize the relationship between RAI1 deficiency and BIC- or TTX-response genes, we examined how individual genes behave upon *Rai1* KD. We found a clear positive correlation between the normal transcriptional response to TTX and the transcriptional impairment by *Rai1* KD at baseline (Spearman rank correlation coefficient r = 0.53, t test p = 2.2 × 10^−16^; [Figure 2](#fig2){ref-type="fig"}D, left panel). BIC-response genes showed no correlation with *Rai1* KD ([Figure 2](#fig2){ref-type="fig"}D, right panel). The group of genes that respond reciprocally to TTX and BIC ([Figure 1](#fig1){ref-type="fig"}F) showed a similar correlation as there was with all TTX-responsive genes ([Figure S2](#mmc1){ref-type="supplementary-material"}D). When we removed all DE genes upon *Rai1* KD from the plot, the correlation remained significant (r = 0.52, p = 2.2 × 10^−16^; [Figure S2](#mmc1){ref-type="supplementary-material"}E), suggesting that the DE genes are not the sole driver for the observed correlation. We also analyzed the published mRNA-seq of the *Rai1*-knockout (KO) cortices ([@bib29]) and found a similar trend in expression pattern of the TTX- and BIC-response genes *in vivo* ([Figure S2](#mmc1){ref-type="supplementary-material"}F). These data show that RAI1 deficiency shifts the transcriptional profile toward the TTX-treated state without drug application and that *Rai1* KD does not affect transcription of non-reciprocal BIC-responsive genes.

RAI1 Deficiency Promotes Synaptic Upscaling {#sec2.3}
-------------------------------------------

Chronic perturbation of neuronal activity by BIC or TTX induces decreases and increases in synaptic strength, which respectively underlie homeostatic synaptic downscaling and upscaling ([@bib1]; [@bib44]; [@bib58]). Given that *Rai1* KD shifted the nascent transcriptome toward the TTX-like state, we asked whether *Rai1* KD would similarly shift excitatory synapse function toward a state similar to synaptic upscaling. We used sparse transfection of DIV 12--14 hippocampal cultures with either *Rai1* or scrambled shRNA and recorded miniature excitatory postsynaptic currents (mEPSCs) from transfected pyramidal-like neurons 48 h later. If *Rai1* KD induces synaptic strengthening in a cell-autonomous manner, we would expect to see a rightward shift in the distribution of mEPSC amplitudes as is observed during synaptic upscaling following chronic activity suppression with TTX. Consistent with this idea, we found that the expression of two distinct shRNAs targeting *Rai1* mRNA each induced a significant increase in baseline mEPSC amplitude ([Figures 3](#fig3){ref-type="fig"}A and 3B), without significantly altering mEPSC frequency or decay time ([Figures 3](#fig3){ref-type="fig"}C and 3D; [Figures S3](#mmc1){ref-type="supplementary-material"}A--S3E). Moreover, *Rai1* KD induced a clear rightward shift in the cumulative probability distribution of mEPSC amplitudes relative to control neurons ([Figure 3](#fig3){ref-type="fig"}E; [Figure S3](#mmc1){ref-type="supplementary-material"}E), an effect that was significantly (albeit partially) rescued by expression of RNAi-resistant RAI1 (F\[2, 41\] = 4.452, p = 0.017; sh-Ctrl, sh-*Rai1* \#1, and rescue, n = 15, 15, and 14; sh-Ctrl versus sh-*Rai1* \#1, p = 0.068; sh-*Rai1* \#1 versus rescue, p = 0.0359; sh-Ctrl versus sh-*Rai1* \#2, n = 14-13, p = 0.0012; [Figures 3](#fig3){ref-type="fig"}A--3E). The shift in distribution of mEPSC amplitudes with *Rai1* KD bears a striking similarity to changes in mEPSC distributions following chronic TTX treatment ([Figure 3](#fig3){ref-type="fig"}F), although *Rai1* KD did not shift mEPSC amplitudes to quite the same degree as TTX. An increase in surface expression of AMPA receptors (AMPARs) at synapses is a signature of synaptic upscaling following activity suppression. Consistent with previous observations, surface expression of the GluA1 AMPAR subunit at PSD-95-labeled excitatory synapses is significantly increased following long-term (24 h) TTX treatment (sh-Ctrl vehicle \[Veh\] versus TTX, n = 13-12, p = 0.0019; [Figure 3](#fig3){ref-type="fig"}G); likewise, we found a similar enhancement of surface GluA1 at synapses following 72 h *Rai1* KD (sh-Ctrl versus sh-*Rai1*, n = 6-6, p = 0.0065; [Figure 3](#fig3){ref-type="fig"}G). Together, these results suggest that reduced *Rai1* expression induces functional changes in excitatory synaptic function that mimic synaptic upscaling induced by activity suppression.Figure 3*Rai1* KD Increases Synaptic Efficacy at Baseline Activity Condition(A--D) Example traces (A) and mean ± SEM mEPSC amplitude (B), frequency (C), and decay time (D) for cultured rat hippocampal primary neurons recorded after transient transfection (48 h) with non-targeting shRNA (sh-Ctrl), *Rai1* targeting shRNA, or sh-*Rai1* \#1 with RNAi-resistant *Rai1*-expressing construct (rescue) at DIV 12--14. Scale bar, 10 pA, 75 ms (sh-Ctrl, sh-*Rai1* \#1, and Rescue, n = 15, 15, and 14, respectively).(E) Cumulative distribution of mEPSC amplitudes of sh-Ctrl (left), sh-*Rai11* (middle), and rescue (right) transfected neurons.(F) Cumulative distribution of mEPSC amplitudes of sh-Ctrl-transfected neurons treated by either vehicle or 1 μM TTX (left) and sh-Ctrl or sh-*Rai1*-transfected neurons (right).(G) Representative images of surface GluA1 (sGluA1, fire), PSD-95 (green), and sGluA1 and PSD-95 (merge) of sh-Ctrl and sh-*Rai1*-infected dendrites. Scale bar, 10 μm. Bar graph of mean sGluA1 signal intensity in PSD-95-positive regions for vehicle or TTX (n = 13-12) and sh-Ctrl or sh-*Rai1* (n = 6-6) treated neurons.(H) Prototypical local field potential recordings from individual electrodes exhibiting a single neuronal unit from cultures transfected with: sh-Ctrl, sh-*Rai1* \#1, or sh-*Rai1* \#2 lentivirus. Scale bars, 500 ms (x axis) and 20 μV (y axis).(I) Firing frequency of individual neuronal units recorded from cultures transfected with sh-Ctrl, sh-*Rai1* \#1, or sh-*Rai1* \#2 (n = 115, 140, and 131 for sh-Ctrl, sh-*Rai1* \#1, and sh-*Rai1* \#2, respectively).All bar graphs represent mean ± SEM. For (B)--(D), one-way ANOVA, followed by post hoc Fisher's least significant difference (LSD) test were performed. For (G), unpaired Student's t tests were performed. For (I), Kruskal-Wallis (K-W) test followed by post hoc Dunn's multiple-comparisons test was performed. K-W: 9.358, p = 0.0003. ^∗^p \< 0.05, ^∗∗^p \< 0.01, and ^∗∗∗^p \< 0.001. See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

Two scenarios could explain the increase in mEPSC amplitude by *Rai1* KD accompanied by TTX-like transcription in resting neurons. The first possibility is that *Rai1* KD suppresses network activity, which in turn indirectly promotes a TTX-like transcriptional program and synaptic upscaling. An alternative possibility is that release of RAI1-mediated suppression of a TTX-responsive transcriptional program directly upscales synapse function. To distinguish these possibilities, we measured ongoing basal network activity of control hippocampal cultures and *Rai1* KD cultures using 60-channel microelectrode arrays (MEAs; [Figures S3](#mmc1){ref-type="supplementary-material"}F and S3G). On DIV 11, we transduced the cultures with LV control or *Rai1* shRNA and recorded network activity on DIV 14. We used semi-automatic principal-component analysis to sort individual neuronal units ([Figures S3](#mmc1){ref-type="supplementary-material"}H--S3K). If the changes in mEPSCs and transcriptional dynamics are an indirect effect secondary to *Rai1* KD suppressing network activity, then we would predict a marked decrease in neural firing. Contrary to this prediction, *Rai1* KD did not suppress firing in the network and instead led to 1.4- to 2.1-fold increase in spontaneous firing rate compared with scrambled shRNA ([Figures 3](#fig3){ref-type="fig"}H and 3I; Kruskal-Wallis test: 9.36, p = 0.009; Dunn's post hoc test: sh-Ctrl versus sh-*Rai1* \#1, p = 0.053; sh-Ctrl versus sh-*Rai1* \#2, p = 0.010), likely because of enhanced excitatory drive that accompanies *Rai1* KD-mediated synaptic strengthening. These data thus support the second explanation, whereby RAI1 suppresses a TTX-responsive transcriptional program and synaptic upscaling in naive neural networks.

RAI1 Promotes Transcriptional Responses Triggered by Reductions in Network Activity {#sec2.4}
-----------------------------------------------------------------------------------

Having uncovered that RAI1 was essential to suppress the TTX-associated transcriptional program under basal activity conditions ([Figure 2](#fig2){ref-type="fig"}), we next tested if *Rai1* KD has any impact on transcriptional responses to TTX and BIC treatments. By calculating fold changes of transcription, we found that *Rai1* KD led to a significant impairment of transcriptional response to TTX, while transcriptional responses to BIC were slightly weaker only for downregulation ([Figure 4](#fig4){ref-type="fig"} A). However, in contrast to the 130 genes transcriptionally altered at baseline, DESeq2 comparing *Rai1* KD and control revealed only 8 DE genes after TTX or BIC treatment, indicating that the impact of *Rai1* KD is greater in resting neurons compared with drug-treated neurons ([Figure 4](#fig4){ref-type="fig"}B; [Table S3](#mmc4){ref-type="supplementary-material"}).Figure 4RAI1 Positively Regulates the Transcriptional Response to TTX(A) The fold changes of TTX- and BIC-response genes in cultures treated by sh-Ctrl or sh-*Rai1* (Wilcoxon rank-sum test). Whiskers represent 1.5 times IQR, and the notch represents the 95% confidence interval of the median.(B) Number of DESeq2-called differentially expressed genes (sh-Ctrl versus sh-*Rai1*, p~adj~ \< 0.05) after TTX, vehicle, or BIC treatment.(C) Incomplete downregulation and upregulation of genes by TTX (left) but not by BIC (right) in *Rai1*-KD cultures. r and p, Spearman's rank correlation coefficient and p value.(D) RAI1-dependent gene ontologies (biological process, p~adj~ \< 0.005) discovered using RNA-Enrich ([@bib40]) and filtered using ReviGO software ([@bib56]).(E) RPKM (reads per kilobase of transcript per million mapped reads) values of four Sig-genes downregulated by *Rai1* KD in the TTX-treated condition. The Sig-genes represent "neurotransmitter transport" (p~adj~ = 9.3 × 10^−8^), the top downregulated biological processes. The remaining Sig-genes are shown in Figure S7. Note slight but consistent inter-replicate changes upon *Rai1* KD.See also [Figure S4](#mmc1){ref-type="supplementary-material"} and [Tables S3](#mmc4){ref-type="supplementary-material"} and [S4](#mmc5){ref-type="supplementary-material"}.

We then sought to determine if the strongly impaired transcriptional response to TTX ([Figure 4](#fig4){ref-type="fig"}A) was due entirely to the TTX-like transcriptional state of *Rai1*-KD cultures at baseline or if RAI1 also contributes to the transcriptional response to TTX. Differential gene expression analysis by DESeq2 relies on an arbitrary statistical significance cutoff to report DE genes. However, the individual gene plot in the baseline condition revealed a global transcriptional trend resulting from minor changes in many genes, including those that failed to achieve statistical significance ([Figure S2](#mmc1){ref-type="supplementary-material"}E). To define the impact of RAI1 loss after TTX and BIC treatment, we therefore used this individual gene plot approach. We found that after TTX treatment, the transcriptional changes of TTX-response genes in *Rai1*-KD cultures inversely correlated with their changes upon TTX treatment in the control condition ([Figure 4](#fig4){ref-type="fig"}C, left panel; Spearman rank correlation coefficient r = 0.32, t test p = 2.2 × 10^−16^). This result indicates incomplete downregulation and upregulation upon TTX treatment independent of the impact of *Rai1* KD in the resting state. The same TTX-response genes did not show obvious changes after BIC treatment of *Rai1-*KD culture ([Figure S4](#mmc1){ref-type="supplementary-material"}A, left panel). Transcription of the BIC-response genes did not show changes by *Rai1* KD under any condition ([Figure 4](#fig4){ref-type="fig"}C, right panel; [Figure S4](#mmc1){ref-type="supplementary-material"}A, right panel). Thus, *Rai1* deficiency leads to a subtle yet widespread impairment of the transcriptional response to TTX but not to BIC. Taken together, these results led us to conclude that RAI1 is selectively required for the transcriptional response driven by network activity suppression.

We then explored biological implications for the impaired transcriptional response to TTX. We used RNA-Enrich, a Gene Ontology algorithm, which takes into account weaker changes in gene expression ([@bib35]; [@bib40]). Notably, RNA-Enrich identified many more RAI1-dependent biological processes after TTX treatment than vehicle or BIC treatment (45 in TTX-treated cultures, 3 in Veh-treated cultures, and 7 in BIC-treated cultures; [Figure 4](#fig4){ref-type="fig"}D). The p~adj~ values were evidently lower in the post-TTX transcriptome data compared with BIC conditions. The RAI1-dependent gene ontologies after TTX treatment represent synapse-related processes, whereas those altered in the BIC and Veh-treated conditions show fewer ontologies directly relevant to neuronal activity ([Figure 4](#fig4){ref-type="fig"}D; [Table S4](#mmc5){ref-type="supplementary-material"}). RNA-Enrich provides the identity of signature genes, called Sig-genes, which contributed to the enrichment of an ontology ([@bib35]; [@bib40]). As expected, Sig-genes for the synapse-related ontologies, including *Ngf*, *Syn3*, *Cacna1b*, and *Rab3a*, showed mild yet reproducible transcriptional changes upon *Rai1* KD ([Figure 4](#fig4){ref-type="fig"}E; [Figure S4](#mmc1){ref-type="supplementary-material"}B).

RAI1 Dissociates from Chromatin in Response to Activity Changes {#sec2.5}
---------------------------------------------------------------

The activity state-dependent requirement of RAI1 in regulating transcription led us to hypothesize that activity shifts of neuronal network might alter RAI1 distribution on chromatin. To test this, we performed chromatin immunoprecipitation coupled with deep sequencing (ChIP-seq) for RAI1 in DIV 17 neuronal cultures treated for 4 h with TTX, BIC, or vehicle. We observed clear RAI1 binding at the promoters of RAI1-dependent genes such as *Homer1* and *Per2* ([Figure 5](#fig5){ref-type="fig"} A). The control ChIP using *Rai1*-KD cultures showed no such events, demonstrating the specificity of ChIP experiments. RAI1 binding was much weaker in TTX- or BIC-treated cultures ([Figure 5](#fig5){ref-type="fig"}A). Consistent with visual observations, peak calling identified only 13 RAI1 peaks across all three *Rai1*-KD ChIP-seq samples (not shown), and they were removed from all subsequent analyses. In shCtrl cells, 6,065 RAI1 peaks were found in the Veh-treated condition, and a drastic reduction of RAI1 peaks upon TTX (98 peaks) and BIC (1 peak) treatments ([Figure 5](#fig5){ref-type="fig"}B). Variable ChIP efficiency or sequencing depth cannot explain the scarce peaks in TTX and BIC conditions, because we spiked in *Drosophila* chromatin and fly-specific H2Av antibody and ensured consistent sequencing depth and ChIP efficiency across the samples ([Figure S5](#mmc1){ref-type="supplementary-material"}A). Neither RAI1 protein levels ([Figure S5](#mmc1){ref-type="supplementary-material"}B) nor nuclear localization ([Figure S2](#mmc1){ref-type="supplementary-material"}A) changed after TTX or BIC treatment. Thus, activity alterations largely release RAI1 from chromatin, which is remarkably consistent with the greater number of RAI1-dependent genes in resting neurons ([Figure 4](#fig4){ref-type="fig"}B).Figure 5Activity-Dependent Chromatin Engagement of RAI1(A) UCSC Browser view of RAI1 ChIP-seq signals at *Rai1*-dependent genes *Homer1* and *Per2*.(B) Number of RAI1 peaks in TTX-, vehicle-, and BIC-treated cultures.(C) RAI1-bound promoters are enriched for activity-response genes (chi-square test, p = 2.2 × 10^−16^).(D) Bimodal RAI1 distribution around TSS. H3K4me3, H3K4me1, H3K27me3, and H3K27ac levels are plotted as controls (see [STAR Methods](#sec3){ref-type="sec"}).(E) Activity-dependent TF motifs enriched in RAI1 peaks.(F) RAI1 directly up- and downregulates transcription in the naive culture.(G) RAI1-bound genes in the TTX condition show incomplete induction and suppression by TTX in *Rai1* KD cells.See also [Figure S5](#mmc1){ref-type="supplementary-material"} and [Table S5](#mmc1){ref-type="supplementary-material"}.

RAI1 Directly Controls Activity-Responsive Gene Transcription in Stable Networks {#sec2.6}
--------------------------------------------------------------------------------

Intersection with BrU-seq data revealed that that RAI1-bound genes are much more likely responsive to network activity shifts than RAI1-free genes (p \< 2.2 × 10^−16^, chi-square test; [Figure 5](#fig5){ref-type="fig"}C; [Figure S5](#mmc1){ref-type="supplementary-material"}C). Consistently, RAI1-bound genes associated with plasticity-related ontologies including synapse organization ([Figure S5](#mmc1){ref-type="supplementary-material"}D). Most of these peaks are present at the promoters in the resting culture ([Figure 5](#fig5){ref-type="fig"}B) and exhibited a bimodal distribution around transcription start sites (TSSs) that harbor H3K4me3 ([Figure 5](#fig5){ref-type="fig"}D). Binding motifs of activity-dependent TFs (e.g., MEF2A, AP1, LHX2, CREB3L) are enriched in RAI1-bound promoters ([Figure 5](#fig5){ref-type="fig"}D). RAI1 also occupied intra- and intergenic regions. In the resting culture, 54% of such non-promoter regions overlapped with DNase-I hypersensitivity sites (DHSs) identified in 8-week-old mouse whole brain ([@bib61]), and the rest were DHS free ([Figure 5](#fig5){ref-type="fig"}B). Some RAI1-bound DHS coincided with H3K4me1 or H3K27ac ([@bib14]), indicating that these elements are likely transcriptional enhancers ([Figure 5](#fig5){ref-type="fig"}B; see [STAR Methods](#sec3){ref-type="sec"}). A substantial fraction (67%) of RAI1 peaks overlapped with previously reported RAI1 peaks in adult mouse brain ([@bib29]) with common TF motifs ([Figures S5](#mmc1){ref-type="supplementary-material"}E and S5F). In sum, these analyses show that RAI1 preferentially engages activity-responsive promoters with H3K4me3 in neural networks with stable basal levels of activity.

Are the RAI1-dependent genes found in BrU-seq direct targets of RAI1? Of the genes up- or downregulated by *Rai1* KD, RAI1 occupied 40 of 122 genes (30%) in the baseline culture, which is significantly higher than the genomic average (p \< 0.05, chi-square test; [Figure S5](#mmc1){ref-type="supplementary-material"}G). The direct targets of RAI1 can be up- or downregulated upon RAI1 loss ([Table S5](#mmc1){ref-type="supplementary-material"}). Of the 18 genes upregulated by *Rai1* KD, RAI1 binds to 10 promoters ([Figure 5](#fig5){ref-type="fig"}F), while RAI1 occupies 29 of 104 genes downregulated by *Rai1* KD. These results support the idea that RAI1 uses both positive and negative regulation to repress the TTX-like transcription state in cultures with stable basal levels of activity ([Figures 2](#fig2){ref-type="fig"}B--2D). Of note, BIC-response genes, which show no dependence on RAI1, also showed RAI1 peak enrichment ([Figure S5](#mmc1){ref-type="supplementary-material"}C); therefore, RAI1 at these genes is dispensable for suppressing BIC-triggered transcription.

RAI1 Directly Contributes to Transcriptional Response to TTX {#sec2.7}
------------------------------------------------------------

Finally, we inspected the 98 RAI1 peaks found in TTX-treated cultures, because we detected a compromised transcriptional response of *Rai1*-KD cells to TTX ([Figures 4](#fig4){ref-type="fig"}C--4E). Most of these peaks were common between the TTX and vehicle conditions (promoter-occupied, 89% overlap; non-promoter-occupied, 77% overlap; [Figure S5](#mmc1){ref-type="supplementary-material"}H). We found a much greater proportion of non-promoter peaks (60%) compared with the resting cells (22%) ([Figure S5](#mmc1){ref-type="supplementary-material"}I). Thus, RAI1 at non-promoter regions preferentially persists when network activity decreases. The genes bound or nearest to these RAI1-TTX peaks showed incomplete induction and suppression upon TTX treatment of *Rai1*-KD cultures ([Figure 5](#fig5){ref-type="fig"}G) but not upon BIC treatment ([Figure S5](#mmc1){ref-type="supplementary-material"}J). These results suggest that RAI1 directly contributes to the transcriptional response (both negative and positive) to TTX and that this role involves primarily non-promoter regulation.

Loss of RAI1 Prevents Synaptic Upscaling but Not Downscaling {#sec2.8}
------------------------------------------------------------

We next examined RAI1's role in homeostatic synaptic scaling induced by chronic activity suppression (TTX, 24 h) or chronic network hyperactivation (BIC, 24 h). Consistent with the misregulation of TTX-responsive genes by *Rai1* KD after TTX treatment ([Figures 4](#fig4){ref-type="fig"} and [5](#fig5){ref-type="fig"}), we found that loss of RAI1 significantly impaired the induction of homeostatic upscaling during activity suppression in a cell-autonomous manner. Following transfection of scrambled or *Rai1*-targeted shRNAs (24 h prior to TTX/BIC), we found that control neurons expressing the scrambled shRNA exhibited the normal increase in mEPSC amplitude 24 h post-TTX (sh-Ctrl Veh versus TTX, n = 29-21, p \< 0.0001; [Figures 6](#fig6){ref-type="fig"}A and 6B) and the distribution of mEPSCs exhibited a clear and multiplicative rightward shift in cumulative frequency plots. In contrast, mEPSCs from neurons expressing either of two distinct *Rai1* shRNAs did not significantly increase following TTX exposure ([Figures 6](#fig6){ref-type="fig"}A--6C). Importantly, expression of an RNAi-resistant RAI1 fully rescued TTX-induced upscaling ([Figures 6](#fig6){ref-type="fig"}A--6C). Despite a clear role in homeostatic upscaling, *Rai1* KD had no effect on the induction of homeostatic downscaling following network hyperactivation with BIC ([Figures 6](#fig6){ref-type="fig"}D--6F). Both control neurons expressing scrambled shRNA and those neurons expressing *Rai1* shRNA exhibited significantly decreased mEPSC amplitudes (sh-Ctrl Veh versus BIC, n = 26-17, p = 0.0026; sh-*Rai1*-\#1 Veh versus BIC, n = 21-8, p = 0.0003; and sh-*Rai1*-\#2 Veh versus BIC, n = 12-8, p \< 0.0001; [Figure 6](#fig6){ref-type="fig"}E), as well as a clear leftward multiplicative shift in mEPSC cumulative probability distributions ([Figure 6](#fig6){ref-type="fig"}F). These results demonstrate that RAI is essential for homeostatic upscaling during activity suppression but is otherwise dispensable for homeostatic downscaling during periods of network hyperactivation.Figure 6*Rai1* KD Impairs Synaptic Upscaling but Not Synaptic Downscaling(A--C) Representative mEPSC traces recorded from neurons transfected with sh-Ctrl, sh-*Rai1*, or rescue and treated with either vehicle or 1 μM TTX. Scale bar, 20 pA, 150 ms.(B) mEPSC amplitude of sh-Ctrl, sh-*Rai1* \#1, sh-*Rai1* \#2, or rescue and treated either with vehicle or TTX (sh-Ctrl Veh, TTX n = 29-21; sh-*Rai1* \#1 Veh, TTX n = 22-7; sh-*Rai1* \#2 Veh, TTX n = 9-8; and rescue Veh, TTX n = 14-15).(C) Cumulative distribution of mEPSC amplitude for sh-Ctrl (left), *Rai1* KD (sh-*Rai1* \#1 + \#2, middle), and rescue (right) comparing vehicle versus TTX.(D--F) Representative mEPSC traces recorded from neurons transfected with either sh-Ctrl or sh-*Rai1* and treated with either vehicle or 10 μM BIC (D). Scale bar, 20 pA, 150 ms. (E) mEPSC amplitude of sh-Ctrl, sh-*Rai1* \#1, and sh-*Rai1* \#2 treated either with vehicle or BIC (sh-Ctrl Veh, BIC n = 26-17; sh-*Rai1* \#1 Veh, BIC n = 21-8; sh-*Rai1* \#2 Veh, BIC n = 12-8). (F) Cumulative distribution of mEPSC amplitude of sh-Ctrl (left) and sh-*Rai1* (sh-*Rai1* \#1 + \#2) treated with vehicle (black) or BIC (blue).All bar graphs are represented as mean ± SEM, and unpaired Student's t tests were performed. ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, and ^∗∗∗∗^p \< 0.0001.

Discussion {#sec2.9}
----------

Our BrU-seq analysis has provided insights into activity-dependent transcriptional regulation. We found widespread transcriptional responses to network activity shifts attributable to BrU-seq's high sensitivity in detecting transcriptional downregulation. Most dynamically regulated genes altered by hyperactivity or suppression are unique rather than reciprocal ([Figure 1](#fig1){ref-type="fig"}). This is interesting given that gene expression studies have focused on reciprocal regulation of genes (e.g., *Arc*, *Fos*, *Homer1*, and *Bdnf*) ([@bib46]). Our results agree with a nascent proteome study on rat hippocampal neurons, in which the authors observed unique, common, and reciprocal changes in protein synthesis upon TTX and BIC treatments ([@bib52]). These observations suggest that besides the reciprocal transcriptional changes of key factors, distinct transcriptional mechanisms may underlie upscaling and downscaling. Our data therefore provide a resource to begin an exploration of such distinct molecular machineries.

Several lines of evidence support a model in which RAI1 acts to constrain synaptic upscaling in networks with baseline levels of activity by preventing premature transcriptional responses normally driven by altered network activity ([Figure 7](#fig7){ref-type="fig"} ). First, RAI1 deficiency shifts gene expression toward TTX-associated transcriptional states ([Figure 2](#fig2){ref-type="fig"}). Second, RAI1 occupies its target promoters strongly in the resting cells and dissociates when network activity shifts ([Figure 5](#fig5){ref-type="fig"}). Third, *Rai1* KD led to an increase in excitatory synaptic strength, reflected by enhanced mEPSC amplitudes and associated with an increase in network firing rate ([Figure 3](#fig3){ref-type="fig"}). Our data further indicate the additional role of RAI1 in promoting synaptic upscaling when the network experiences prolonged activity depression ([Figure 6](#fig6){ref-type="fig"}). This latter role of RAI1 again involves direct control of TTX-induced transcriptional responses ([Figures 4](#fig4){ref-type="fig"} and [5](#fig5){ref-type="fig"}). The most remarkable aspect of these observations might be the predictive capability of BrU-seq results for RAI1's roles in chromatin regulation and synaptic plasticity.Figure 7RAI1's Role as a State-Dependent Transcriptional Regulator of TTX-Response GenesRAI1 alters synaptic efficacy through activity-dependent chromatin binding and plays essential roles in regulating TTX-response genes under baseline and activity-suppressed states.

The present work provides insights into RAI1-mediated regulation of gene transcription. RAI1 is a nucleosome-binding protein and is thought to act as a transcriptional coactivator ([@bib7]). Our data demonstrate that RAI1 can also repress transcription depending on the target genes ([Figure 5](#fig5){ref-type="fig"}). We could not identify genomic features that separate coactivator and corepressor functions (not shown), but other studies suggest some possibilities. Like RAI1, TET3 and EHMT1/2 have important roles in homeostatic upscaling ([@bib4]; [@bib66]). While TET3 positively regulates transcription by removing CpG methylation ([@bib33]), EHMT1/2 generally acts as a transcriptional repressor by placing the repressive histone H3K9 methylation mark ([@bib57]). Thus, the two facets of RAI1's role in transcriptional dynamics could be through interactions with positive and negative transcriptional regulators, such as TET3 and EHMT1/2.

It is noteworthy that all the four previously characterized chromatin regulators in synaptic scaling (i.e., TET3, EHMT1/2, and L3MBTL1) were chosen for investigations, because network activity alters their expression or target histone modifications ([@bib4]; [@bib43]; [@bib66]). We found no indication that neuronal activity influences RAI1 expression ([Figures S2](#mmc1){ref-type="supplementary-material"}A and S5B). These observations suggest that chromatin regulators linked to human cognitive disorders could participate in synaptic scaling and other forms of transcription-dependent plasticity, even when their expression remains stable during the process. The predominant chromatin occupancy by RAI1 during stable periods of network activity ([Figure 5](#fig5){ref-type="fig"}) is unique among the scaling-associated chromatin factors, which all appear to be activated by network activity alterations. Post-translational modifications on RAI1 itself or chromatin are potential mechanisms for the RAI1 dissociation from chromatin. Thus, RAI1 offers a molecular mechanism that stabilizes network activity, and future investigations may uncover a similar mode of action in other chromatin regulators associated with human cognitive deficits.

How do RAI1's roles in synaptic scaling relate to cognitive function? Thorough characterization of cell type-specific *Rai1*-KO mice attributed their learning deficits to GABAergic interneurons rather than glutamatergic excitatory neurons ([@bib29]). Because we measured mEPSCs in the pyramidal cells that incorporated the sparsely transfected *Rai1*-shRNA plasmid, RAI1's role in synaptic scaling is cell autonomous to excitatory neurons. The lack of learning deficits in forebrain-specific *Rai1*-KO (*Emx1*-Cre: *Rai1* ^flox/flox^) may suggest that impaired cognitive function is independent of RAI1's role in synaptic scaling. Alternatively, unknown genes may compensate for synaptic scaling deficits during development thus obscuring the contribution of RAI1 in excitatory neurons that can only be seen in acute RAI1 deficiency. Of note, a recent study reported reduced dendritic spine density in the prefrontal cortex of 4-week-old *Rai1*-heterozygous mice ([@bib30]), which are genetically similar to SMS patients. The spine deficits in *Rai1*-heterozygous mice may relate to RAI1's role in synaptic upscaling identified here. Identifying RAI1-target genes that mediate the synaptic phenotype will illuminate the molecular pathways underlying the cell-autonomous roles of RAI1.

A limitation of the BrU-seq approach is the lack of cell type specificity. Recently, [@bib67] reported nascent RNA-seq specifically in neurons. They used *Synapsin I* promoter-driven expression of uracil phosphoribosyltransferase (UPRT) to label RNAs of neurons. The UPRT system identified more than 3,000 depolarization-regulated genes over the 3 h KCl treatments, which likely detected both nascent transcripts and steady-state mRNAs. Cell type specificity of the UPRT system comes with the cost of introducing the UPRT transgene and additional experimental steps to label RNAs. Furthermore, single-cell RNA-seq of *Rai1*-KD neurons might illuminate cell type-specific roles for RAI1. Single-cell RNA-seq, however, mostly characterizes poly(A)-selected steady-state mRNAs. Thus, it will be important to choose the most suitable experimental approach for RNA profiling depending on specific goals of the study.

Our RAI1 ChIP-seq study involves a single replicate because of the unexpected and sustained laboratory closures during the ongoing coronavirus disease 2019 (COVID-19) pandemic. When laboratory operations resume, we plan to collect data of a second replicate and share the data via the GEO database. Our ChIP-seq data, nonetheless, include robust controls (i.e., *Rai1*-KD samples and internal spike-in controls); therefore, it is unlikely that the conclusion will change with new datasets.

In summary, our results indicate that nascent RNA-seq with BrU-seq uncovers robust and dynamic transcriptional responses during alterations in network activity. Transcriptional changes are largely unique in response to network hyperactivation or suppression, rather than reciprocal. Our studies further identify a unique role for RAI1 in homeostatic synaptic plasticity, whereby during stable patterns of activity, it suppresses a transcriptional program engaged during activity suppression. These findings illuminate principles whereby dysregulated chromatin signaling may contribute to neurodevelopmental disorders.

STAR★Methods {#sec3}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**anti-BrdU antibodySanta Cruz BiotechnologyCat. No. sc-32323; RRID: [AB_626766](nif-antibody:AB_626766){#interref60}anti-PCNA antibodySanta Cruz BiotechnologyCat. No. sc-56; RRID: [AB_628110](nif-antibody:AB_628110){#interref65}anti-beta-actin antibodySigmaCat. No. A5441; RRID: [AB_476744](nif-antibody:AB_476744){#interref70}HRP-conjugated secondary anti-IGG antibodyEMD MilliporeCat. No. AP132P/Cat. No. AQ160P; RRID: [AB_90264](nif-antibody:AB_90264){#interref80}; RRID: [AB_92795](nif-antibody:AB_92795){#interref75}anti-NeuNEMD MilliporeCat. No. MAB377; RRID: [AB_2298772](nif-antibody:AB_2298772){#interref85}anti-GFAPNeuroMabCat. No. N206A/8; RRID: [AB_10672298](nif-antibody:AB_10672298){#interref90}anti-MAP2EMD MilliporeCat. No. AB5543; RRID: [AB_571049](nif-antibody:AB_571049){#interref95}anti-OLIG2EMD MilliporeCat. No. AB9610; RRID: [AB_570666](nif-antibody:AB_570666){#interref100}anti-CD11bAbcamCat. No. ab133357; RRID: [AB_2650514](nif-antibody:AB_2650514){#interref105}anti-GAD67Santa CruzCat. No. sc-5602; RRID: [AB_2107748](nif-antibody:AB_2107748){#interref110}anti-GluA1EMD MilliporeCat. No. ABN241; RRID: [AB_2721164](nif-antibody:AB_2721164){#interref115}anti-PSD95EMD MilliporeCat. No. MAB1596; RRID: [AB_2092365](nif-antibody:AB_2092365){#interref120}**Bacterial and Virus Strains**pMD.2G plasmid for lentiviral productionAddGenePlasmid \#12259; RRID: Addgene_12259psPAX2 plasmid for lentiviral productionAddGenePlasmid \#12260; RRID: Addgene_12260**Chemicals, Peptides, and Recombinant Proteins**5-BromouridineSigmaCat. No. 18670bicuculline-methiodideAbcamCat. No. ab120108Tri-Reagent BDSigmaCat. No. T3809DNase INew England BiolabsCat. No. M0303RNA ligase 1New England BiolabsCat. No. M0437truncated RNA ligase KQNew England BiolabsCat. No. M0373**Deposited Data**RAI1 Bru-seq/ChIP-seq dataGene Expression OmnibusGEO: [GSE121749](ncbi-geo:GSE121749){#interref125}DNase-Hypersensitivity sites, Mouse brain E14.5[@bib61]GEO: [GSM1014197](ncbi-geo:GSM1014197){#interref130}DNase-Hypersensitivity sites, Mouse brain 8 week adult[@bib61]GEO: [GSM1014151](ncbi-geo:GSM1014151){#interref135}H3K4me1 ChIp-seq, mouse brain, 8 week[@bib20]GEO: [GSM769022](ncbi-geo:GSM769022){#interref140}H3K4me1 ChIp-seq, mouse brain, E14.5[@bib20]GEO: [GSM1000096](ncbi-geo:GSM1000096){#interref145}H3K4me3 ChIP-seq, mouse brain, 8 week[@bib20]GEO: [GSM769026](ncbi-geo:GSM769026){#interref150}H3K4me3 ChIP-seq, mouse brain, E14.5[@bib20]GEO: [GSM1000095](ncbi-geo:GSM1000095){#interref155}H3K27ac ChIP-seq mouse brain, E14.5[@bib20]GEO: [GSM1000094](ncbi-geo:GSM1000094){#interref160}H3K27ac ChIP-seq mouse brain 8 week[@bib10]GEO: [GSM3666438](ncbi-geo:GSM3666438){#interref165}H3K27me2 ChIP-seq mouse brain E14.5[@bib20]GEO: [GSM1000143](ncbi-geo:GSM1000143){#interref170}H3K27me3 ChIP-seq mouse brain, 8 week[@bib10]GEO: [GSM3666437](ncbi-geo:GSM3666437){#interref175}**Experimental Models: Organisms/Strains**Mouse:CD-1Charles RiverStrain 022Rat:Sprague-DawleyCharles RiverStrain 001**Oligonucleotides**RNA-sequencing library preparation primersSee [Table S6](#mmc1){ref-type="supplementary-material"} for primers usedN/A**Recombinant DNA**full-length human RAI1 cDNAreverse transcription from human cell linesGenBank: NM_030665.3**Software and Algorithms**Bowtie1[@bib39]N/ABowtie2[@bib38]N/AWe used MACS2[@bib68]version 2.1.0.20140616DESeq2[@bib42]N/ATophat2[@bib36]N/ALRPath/RNAEnrich[@bib35]N/ACustom MEA analysis<https://github.com/Jcrd25/NeuroMEACode>N/A

Resource Availability {#sec4.2}
---------------------

### Lead Contact {#sec4.2.1}

Further information and requests for resources and reagents should be directed to and will be fulfilled by Shigeki Iwase (<siwase@umich.edu>)

### Materials Availability {#sec4.2.2}

There are restrictions to the availability of the custom RAI1 antibody due to limited supply.

### Data and Code Availability {#sec4.2.3}

Sequencing data generated for this study have been submitted to the NCBI Gene Expression Omnibus (GEO; <https://www.ncbi.nlm.nih.gov/geo/>) under accession number [GSE121749](ncbi-geo:GSE121749){#intref0035}.

Custom MEA analysis scripts can be found at <https://github.com/Jcrd25/NeuroMEACode>

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Primary Mouse Forebrain Cultures {#sec4.3.1}

Cortices and hippocampi from E18.5 CD1 mouse pups (Charles River, Strain 022) were pooled into biological replicates with identical female:male ratios. Sex of the pups was determined by PCR using primers for the ZFY gene ([Table S6](#mmc1){ref-type="supplementary-material"}). Primary culture of neurons was carried out as previously described ([@bib34]; [@bib60]). Briefly, dissociated tissues were plated at 4 million cells/6 cm poly-D-lysine-coated plate (Sigma) grown in Neurobasal Media supplemented with B27 (GIBCO, \#17504044). No mitotic inhibitors or antibiotics were added. Half the culture medium was freshened every 3-5 days.

### Primary Rat Hippocampal Cultures {#sec4.3.2}

All animal use followed NIH guidelines and was in compliance with the University of Michigan Committee on Use and Care of Animals. Dissociated postnatal (P0-3) hippocampal neuron cultures were prepared from Sprague-Dawley rats (Charles River, Strain 001) as previously described ([@bib71]). Sex of rat pups was not determined. For MEA experiments, neurons were plated onto sterile multi-electrode arrays chips (MEAs) (60MEA200/30IR--TI; Multichannel Systems, Reutlingen, Germany) at a density of ∼350 cells/mm2. MEAs were coated with 0.05% polyethyleneimine and laminin (1 ug/ul). MEAs were transferred to the incubator for \> 3 h to allow for cell adhesion. Media was composed of Neurobasal Plus Medium with 1X B-27 Plus supplement, 1X GlutaMax and 50 U/ml of Pen/Strep (ThermoFisher, Waltham, MA). MEAs were covered with a gas permeable ethlylene propylene membrane (MEA-MEM, Multichannel Systems, Reutlingen, Germany). Half-volume media exchanges were done every 3-4 days. Cultures that exhibited spontaneous spiking activity on ≥ 10 electrodes on DIV10 were considered healthy and included in the study.

Method Details {#sec4.4}
--------------

### Lentivirus preparation {#sec4.4.1}

Lentivirus were generated using co-transfection into HEK293t cells of psPAX2 (Addgene, 12260), pMD2.G (AddGene, 12259) and pLKO plasmids containing shRNA against *Rai1* untranslated region (*Rai1*-shRNA \#1: Sigma, TRCN0000124984) or coding region (*Rai1*-shRNA \#2: Sigma, TRCN0000328334) or scramble shRNA (Sigma, SHC202). For Bru-seq and ChIP-seq experiments, we used SHC202 and *Rai1*-shRNA \#1. For electrophysiology, we used SHC202, *Rai1*-shRNA \#1 and \#2, whose target sequences are identical between mouse and rat. The conditioned media containing lentiviruses was collected, concentrated with Lenti-X concentrator (Takara, 631232), and resuspended in Neurobasal medium, and stored at −80°C. The titer of lentivirus was determined by survival of transduced 293 cells under puromycin and a comparable amount of virus that result in \>90% survival of infected neurons was used for all biological replicates.

### Activity Alteration and Bru-seq {#sec4.4.2}

On DIV14, cells were infected with lentiviral shRNA as previously described ([@bib60]). On DIV17, cells were treated with bicuculline-methiodide (Abcam, ab120108, 20 μM), TTX (Tocris, 1069, 1 μM), or vehicle (sterile water), for 4 h. 3 h, and 40 min post treatment, bromouridine (Bru, Sigma, 18670, dissolved in PBS) was added to cultures at 2 mM final concentration. Cultures were harvested in Tri-reagent BD (Sigma, T3809) and frozen immediately. RNA was purified using phenol-chloroform extraction and isopropaonol precipitation, treated with DNase-I (NEB, M0303) then fragmented by high-magnesium, high temperature incubation. From 1 μg of total RNA, enrichment of Bru-containing RNA and library preparation were performed as previously described ([@bib48], [@bib49]) with minor modifications. We designed custom adaptors ([Table S6](#mmc1){ref-type="supplementary-material"}) which were directly ligated to the 3′ ends of RNA using RNA ligase 1 (NEB Cat. No. M0437) and truncated RNA ligase KQ (NEB M0373). Bromouridine-labeled RNAs were immunoprecipitated using anti-BrdU antibody (Santa Cruz Biotechnology, sc-32323). Enriched RNAs were reverse transcribed using a primer complementary to the RNA adaptor ([Table S6](#mmc1){ref-type="supplementary-material"}). Adaptor duplexes with 5- or 6-base pair random nucleotide overhangs were ligated to the 3′ end of the cDNA ([Table S6](#mmc1){ref-type="supplementary-material"}). The cDNA libraries were amplified using primers that carry Illumina indices, then 180-400 bp DNA fragments were isolated using by an agarose gel. The nucleotide sequences of primers used for library amplification are found in [Table S6](#mmc1){ref-type="supplementary-material"}. The libraries were subjected to single-end 50-bp sequencing using IIlumina HiSeq 2000 platform.We performed 2 to 3 biological replicates for all drug treatment and knockdown conditions.

### ChIP-seq {#sec4.4.3}

ChIP was performed as previously described ([@bib34]). We dissociated E18 mouse forebrains and culture them for 14 DIV, infected with lentivirus containing sh-*Rai1* \#1 or sh-Ctrl. On DIV17, we treated cultures with 2 μM TTX, 20 μM BIC, or water vehicle for 4 h, harvested the cells, fixed with 1% formaldehyde in HBSS for 30 min at room temperature, and prepared chromatin samples. We digested chromatin first with MNase for 20 min at 25°C. We then spiked, *Drosophila* chromatin, which contains fly-specific histone variant H2Av (Active Motif Cat. No. 53083). Samples were then further sheared by sonication using Qsonica Q800R3 at 70% amplitude 15 s pulse with 20 s interval for 30 min (total time: 70 min). The antibodies applied were the abovementioned anti-RAI1 polyclonal and anti-*Drosophila* H2Av antibodies (2.5 μg/sample). Antibody-antigen complex that formed at 4°C overnight were precipitated with Dynabeads Protein A/G mixture (1:1, Invitrogen 10001D, 10003D). We isolated the pulled down DNA and made sequencing libraries with NEBNext reagents (E7645S) and sequenced them on the Illumina HiSeq4000 platform to generate 50 bp single-end reads.

### Patch-Clamp Electrophysiology {#sec4.4.4}

Neurons were transfected with 1.0 μg of either sh-Ctrlor sh-*Rai1* \#1 or \#2. For the rescue experiments, an RNAi-resistant RAI1-expression plasmid or its empty vector were co-transfected with the above shRNA expressing plasmids. Transfections were performed using CalPhos Transfection kit (ClonTech) or Lipofectamine 2000 (ThermoFisher Scientific) according to the manufacturer's protocols. All experiments were performed 48 h after transfection. To induce synaptic scaling, neurons were treated with either 1 μM TTX, 10 μM bicuculine or vehicle for 24hr prior to recording. mEPSCs were recorded from a holding potential of -- 70 mV with an Axopatch 200B or Multiclamp 700B amplifier from neurons bathed in HEPES buffered saline (HBS) containing: 119 mM NaCl, 5 mM KCl, 2 mM CaCl2, 2 mM MgCl2, 30 mM Glucose, 10 mM HEPES (pH 7.4) plus 1 μM TTX and 10 μM bicuculline.

### Multi-Electrode Array Electrophysiology {#sec4.4.5}

On DIV11, neurons were transfected with lentivirus encoding sh-Ctrl or sh-*Rai1* \#1 or \#2 by performing a half-media change. On DIV14, Local Field Potential (LFP) recordings were acquired at 20 kHz using a MEA2100-System (Multichannel Systems, Reutlingen, Germany). MEA chips were secured to the headstage of the amplifier and maintained in a controlled environment (37°C, 5% CO2) for the duration of the recording. Prior to recording, MEAs were undisturbed for eight min to allow for acclimation after handling.

### Immunofluorescence {#sec4.4.6}

Surface GluA1 staining was conducted as previously described with slight modification ([@bib71]). On DIV12, rat cultured hippocampal cells were infected either with lentivirus carrying sh-Ctrl or sh-*Rai1* as described above. After 72 h of incubation, cultured cells were live-labeled with rabbit anti-GluA1 antibody (10 μg/ml, EMD Millipore, ABN241) for 20 min at 37°C, fixed with 2% paraformaldehyde, and further labeled with mouse anti-PSD-95 (EMD Millipore, MAB1596, 1:1000). Goat anti-mouse Alexa 488 and Goat anti-rabbit Alexa 555 secondary antibodies (Abcam, 1:500) were applied for 60 min at room temperature to visualize PSD-95 and GluA1 staining. Images of PSD-95 and GluA1 were acquired blinded tocondition using an inverted Olympus FV1000 laser-scanning confocal microscope using a Plan-Apochromat 63 X /1.4 oil objective.

For RAI1 and cell-type marker staining, two biological replicates of forebrain neuron cultures were obtained from E17.5 mouse embryos. On DIV19, they were fixed with 4% paraformaldehyde in 16% sucrose/PBS, permeabilized with 0.25% Triton-X in 1X PBS, blocked for 30 min with 10% bovine albumin serum (Sigma A2153), and overnight incubation of antibodies in 3% BSA at 4°C.Primary antibodies used in the study are following. anti-NeuN (EMD Millipore, MAB377, 1:1000), anti-GFAP (NeuroMab N206A/8, 1:1000), anti-MAP2 (EMD Millipore, AB5543, 1:1000), anti-OLIG2 (EMD Millipore, AB9610, 1:1000), anti-CD11b (Abcam, ab133357, 1:500), anti-GAD67 (Santa Cruz, sc-5602, 1:1000). Secondary antibodies (Invitrogen Alexa Fluor 488, 555, or 647) were applied for 45 min at room temperature. Fluorescence images were acquired blinded to condition using an Olympus BX61 fluorescence microscope (60X oil-immersion lens) and CellSense software.

### Western Blot {#sec4.4.7}

To validate *Rai1*-KD in mouse forebrain neuron culture, *Rai1*-KD and control cultures were harvested at 3 days after lentiviral transduction and subjected to western blot analysis as described previously ([@bib34]). RAI1 antibodies were generated by immunizing rabbits with a synthesized RAI1 peptide (aa 28 to 42, ENYRQPGQAGLSCDR, Thermo Fisher Scientific), followed by affinity purification using the peptide as the affinity ligand (Thermo Fisher Scientific). Anti-PCNA antibody (Santa Cruz sc-56, 1:1000) was used for a loading control. For analysis of RAI1 level during activity shifts, the cortices from E18.5 rat pups were dissected, dissociated, and plated at 700,000 cells/well in a PDL-coated 6-well dish. Neurons were grown in Neurobasal/B27 medium for 14 DIV. Vehicle (1% water), TTX (1 μM) or BIC (20 μM) were added to the culture and cells were harvested with a 1:1 mixture of 2X Laemmeli buffer (BioRad, 1610737, 1:20 beta-mercaptoethanol) and radioimmunoprecipitation assay (RIPA) buffer supplemented with 50 mM BGP and 1 mM Na3VO4. Protein samples were boiled for 10 min at 100°C. 10-15 μg of each sample was loaded per lane, separated by 7.5% SDS-PAGE, and transferred onto PVDF membrane (Millipore IPVH00010). Membranes were then blocked with 5% skim milk or 3% blotting-grade blocker (BioRad 1706404) for 1 hr, probed overnight with the following primary antibodies diluted in 3% BSA (Fisher Scientific BP1600): RAI1 (1:1000), beta-actin (Sigma A5441, 1:20,000). Horseradish peroxide (HRP)-conjugated secondary IgG antibodies (EMD Millipore AP132P or AQ160P) were also diluted in 3% BSA, and the HRP signal was developed with various chemiluminescent substrates from Thermo Fisher Scientific (34080 or 34095) and Li-COR Biosciences (926-95000).

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

### Bru-seq Activity-Induction {#sec4.5.1}

After confirming the quality of sequencing data by FastQC, reads were mapped to mm9 reference genome using Bowtie2 ([@bib38]) and annotated with Tophat2 ([@bib36]). Adaptors were trimmed using BBDUK (<https://jgi.doe.gov/data-and-tools/bb-tools/>), when 2-30 bp on the left of the read matched the predicted adaptor (k = 30, mink = 2, minlength = 15, hdist = 1). Bru-seq signals were quantified by FeatureCounts ([@bib41]). We excluded *Rn45s*, *Lars2*, *Rn4.5 s*, *Cdk8*, *Zc3h7a* and the mitochondrial chromosome to avoid counts of overamplified genes that may skew RPKM normalization. DE-genes were identified using DESeq2 ([@bib42]) using the same parameters for the Bru-seq data and three published mRNA-seq datasets of neuron culture and *Rai1*-KO mice ([@bib29]; [@bib53]; [@bib66]). We also used DESeq2 to calculate RPKM expression values across the entire genic regions, including introns. Correlation analyses used base R Spearman Rank correlation test coupled with t tests to avoid the effect of extreme outliers ([Figures 2](#fig2){ref-type="fig"}, [4](#fig4){ref-type="fig"} and [S5](#mmc1){ref-type="supplementary-material"}). Fold change comparisons were tested using the non-parametric Wilcoxon rank-sum/Mann-Whitney U test ([Figures 1](#fig1){ref-type="fig"} and [4](#fig4){ref-type="fig"}) Gene ontology was examined using RNA-Enrich ([@bib40]). Significance cutoff for reporting Sig-genes was an unadjusted p value \< 0.05. We only presented GO terms that contain 5 to 250 genes.

### ChIP-seq {#sec4.5.2}

Raw reads were demultiplexed and filtered according to the standard Illumina analysis pipeline. Reads from sequencing libraries were then mapped to the mouse (mm9) and fruit fly (dm6) genome assemblies using Bowtie1 ([@bib39]) allowing up to 2 mismatches. Only uniquely-mapped reads were used for analysis. We used MACS2 (version 2.1.0.20140616, FDR \< 0.01) to identify RAI1 peaks using pooled input samples as a control ([@bib68]). For visualization in the UCSC browser, bigwig files were generated with coverage normalized using the number of mapped reads to the *Drosophila* genome (reads mapped per reference genome per million reads) ([@bib18]; [@bib47]). ChIPseeker ([@bib65]) annotated RAI1 peaks to promoters, genic, or intergenic regions. We integrated following publically available epigenomic datasets: DNase I hypersensitive sites (DHS) of whole brain samples ([@bib61]) (E14.5: GEO: [GSM1014197](ncbi-geo:GSM1014197){#interref180}, 8 week adult: GEO: [GSM1014151](ncbi-geo:GSM1014151){#interref185}), H3K4me1([@bib20]): whole brain (8 week: GEO: [GSM769022](ncbi-geo:GSM769022){#interref190}, E14.5: GEO: [GSM1000096](ncbi-geo:GSM1000096){#interref195}), H3K4me3 ([@bib20]): whole brain (8 week: GEO: [GSM769026](ncbi-geo:GSM769026){#interref205}, E14.5: GEO: [GSM1000095](ncbi-geo:GSM1000095){#interref200}): H3K27ac (E14.5 whole brain ([@bib20])): GEO: [GSM1000094](ncbi-geo:GSM1000094){#interref210}, 8 week forebrain ([@bib10]): GEO: [GSM3666438](ncbi-geo:GSM3666438){#interref215}): and H3K27me (E14.5 H3K27me2 whole-brain ([@bib20]): GEO: [GSM1000143](ncbi-geo:GSM1000143){#interref225}, 8 week H3K27me3 forebrain ([@bib10]), GEO: [GSM3666437](ncbi-geo:GSM3666437){#interref220}). Putative transcriptional enhancers were defined as DHS-positive RAI1 peaks (±500 bp) that overlap with H3K4me1 but not H3K4me3. Correlation analyses used base R Spearman Rank correlation test coupled with t tests to avoid the effect of extreme outliers ([Figures 5](#fig5){ref-type="fig"} and [S5](#mmc1){ref-type="supplementary-material"}). Enrichment analysis was tested using Chi-square test ([Figures 5](#fig5){ref-type="fig"} and [S5](#mmc1){ref-type="supplementary-material"})

### Patch-Clamp Electrophysiology {#sec4.5.3}

Miniature EPSCs were analyzed offline using MiniAnalysis. Statistical differences between experimental conditions were determined by unpaired Student's t tests ([Figure 6](#fig6){ref-type="fig"}) or one-way ANOVA followed by post hoc Fisher's LSD test ([Figure 3](#fig3){ref-type="fig"}).

### Multi-Electrode Array Electrophysiology {#sec4.5.4}

Spontaneous activity was captured during 5 min epochs. Data were imported into MATLAB (MathWorks, Natick, MA) and analyzed using custom written scripts (<https://github.com/Jcrd25/NeuroMEACode>) The LFP signal was high pass filtered at 100 Hz using a Butterworth filter. Spikes were detected using amplitude thresholds set at five times the root mean square of the noise. Neuronal units were identified by spike sporting using principal component analysis of the detected spike and manually identifying clusters. A spike was defined by the signal 1 ms before the peak to 3 ms after the peak. The inter spike interval was defined as the time between two adjacent spikes. Mean firing frequency was calculated by dividing the total number of spikes detected for each neuronal unit by the recording duration. Statistical analyses were done in MATLAB and GraphPad Prism (GraphPad Software, San Diego, CA). Kruskal-Wallis test followed by post hoc Dunn's multiple comparisons test were performed on data from three biological replicates.

### Immunofluorescence {#sec4.5.5}

For RAI1 and cell-type marker staining, immunoreactivity was quantified blinded to condition and semi-automatedly using ImageJ after confirming specific staining by visual inspection.

For synaptic GluA1 staining, synaptic GluA1 was anlayzed on maximal intensity z-projections. Synaptic GluA1 was defined as a particle that occupied \>10% of the PSD-95 positive area, and the average integrated intensity of synapatic GluA1 was calculated using custom-written analyses on ImageJ and MATLAB. Statistical differences between experimental conditions were determined by unpaired Student's t tests.

### Western blot {#sec4.5.6}

Protein band intensity was visualized and quantified in the linear range using LI-COR C-Digit and Image Studio software. Three biological replicates were used. Results were compared using one-way ANOVA with Dunnett's test.
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